Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Harbour BioMed resubmits BLA for batoclimab to China’s NMPA for generalized myasthenia gravis Harbour BioMed (HKEX: 02142), a prominent global biopharmaceutical company, has announced the resubmission of the Biologics License Application… byPallavi MadhirajuJune 27, 2024